El uso de agentes antiplaquetarios para la tromboprofilaxis arterial en la COVID-19-Reference-Cited by-同舟云学术

El uso de agentes antiplaquetarios para la tromboprofilaxis arterial en la COVID-19

Published:2021-01 Issue:1 Volume:74 Page:114-115
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Kow Chia Siang,Hasan Syed Shahzad

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Arterial thrombotic complications in hospitalized patients with COVID-19;Rey;Rev Esp Cardiol,2020

2. D, L-lysine acetylsalicylate+glycine impairs coronavirus replication;Müller;J Antivir Antiretrovir.,2016

3. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19 [published online ahead of print, 2020 Apr 20];Liu;Acta Pharm Sin B.,2020

4. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome;Ranucci;J Thromb Haemost.,2020

5. Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study;Viecca;Pharmacol Res.,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Some Antiplatelet Salts as Drug Active Ingredients and Investigation Biological Activities;Pharmaceutical Chemistry Journal;2023-11

2. Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”;Heart & Lung;2023-03

3. Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises;Biophysical Chemistry;2022-11

4. Concomitant renal and splenic infarctions in a COVID-19-patient with a catastrophic thrombotic syndrome;Radiology Case Reports;2022-10

5. Possible role of pannexin 1 channels and purinergic receptors in the pathogenesis and mechanism of action of SARS-CoV-2 and therapeutic potential of targeting them in COVID-19;Life Sciences;2022-05